Skip to the content
Seraxislogo darklogo light
  • Home
  • Technology
  • Pipeline
  • About
    • Leadership
    • Press Releases
    • In the News
    • Publications & Presentations
    • Contact Us
Search
Seraxis
  • Home
  • Technology
  • Pipeline
  • About
    • Leadership
    • Press Releases
    • In the News
    • Publications & Presentations
    • Contact Us
HomePresentationEvercore ISI 2024 Emerging Private Biotech Conference.
Presentation

Evercore ISI 2024 Emerging Private Biotech Conference.

admin
February 29, 2024
Video presentation, Pancreatic Islet Replacement Therapy:  A functional cure for diabetes (Registration required). WL Rust, CEO, February 29, 2024.

About Seraxis, Inc.

Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes.

Video
Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
  • .pn-icon{fill:#fff;}
Previous post
Seraxis’ manufacturing suite completes GMP quality system audit ahead of SR-02 IND filing and transplantation of pancreatic clusters to patients with Type 1 Diabetes.

Related articles

Stem Cells Translational Medecine
Presentation
Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes.
admin
November 12, 2018
Seraxis, Inc.

Seraxis, Inc | 20400 Century Blvd, Suite 150 | Germantown, MD 20874

Home

Technology

Publications & Presentations

Pipeline

About

Press Releases

Contact Us

© 2026 Seraxis, Inc. All Rights Reserved

Back to top Drag
w
  • Services
  • Careers
  • Contact Us